Skip to main content
. 2020 Jun 8;21(8):1245–1257. doi: 10.1007/s10198-020-01195-8

Fig. 1.

Fig. 1

Flow chart for inclusion of PE guidelines in the review. CUA cost-utility analysis, HTA health technology assessment, MAUI multi-attribute utility instrument, PE pharmacoeconomic